AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$595M |
| 2 |
Verisk Analytics
VRSK
|
+$499M |
| 3 |
Otis Worldwide
OTIS
|
+$484M |
| 4 |
lululemon athletica
LULU
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$384M |
| 2 |
Nike
NKE
|
+$341M |
| 3 |
Arista Networks
ANET
|
+$335M |
| 4 |
Visa
V
|
+$331M |
| 5 |
Cognizant
CTSH
|
+$308M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.66% |
| 2 | Healthcare | 18% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Fate Therapeutics
FATE
$283M
| $343K | ﹤0.01% |
161,560
+34,430
| +27% | +$114K |
|
2752
Insteel Industries
IIIN
$624M
| $342K | ﹤0.01% |
10,550
-700
| -6% | -$22.5K |
|
2753
Bally's
BALY
$686M
| $342K | ﹤0.01% |
26,100
| – | – |
|
2754
Rigel Pharmaceuticals
RIGL
$692M
| $340K | ﹤0.01% |
31,473
-1,225
| -4% | -$14.7K |
|
2755
Donegal Group Class A
DGICA
$701M
| $340K | ﹤0.01% |
23,834
-160
| -0.7% | -$2.34K |
|
2756
ATN International
ATNI
$364M
| $339K | ﹤0.01% |
10,750
-160
| -1% | -$5.69K |
|
|
EGRX
2757
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $337K | ﹤0.01% |
21,390
-23,162
| -52% | -$416K |
|
2758
Aldeyra Therapeutics
ALDX
$95.3M
| $337K | ﹤0.01% |
50,440
-170,090
| -77% | -$1.26M |
|
2759
DXP Enterprises
DXPE
$2.57B
| $336K | ﹤0.01% |
9,630
-1,510
| -14% | -$54.5K |
|
2760
KRONOS Worldwide
KRO
$705M
| $335K | ﹤0.01% |
43,230
-1,750
| -4% | -$15.2K |
|
|
EBIX
2761
DELISTED
Ebix Inc
EBIX
| $335K | ﹤0.01% |
33,890
+7,340
| +28% | +$143K |
|
2762
Teekay
TK
$974M
| $334K | ﹤0.01% |
54,180
-5,570
| -9% | -$35.5K |
|
|
HRT
2763
DELISTED
HireRight Holdings Corporation
HRT
| $334K | ﹤0.01% |
35,070
+1,730
| +5% | +$17.8K |
|
2764
Five Star Bancorp
FSBC
$1.01B
| $333K | ﹤0.01% |
16,624
+390
| +2% | +$8.71K |
|
2765
Driven Brands
DRVN
$2.37B
| $333K | ﹤0.01% |
26,420
-5,584,052
| -100% | -$102M |
|
2766
i3 Verticals
IIIV
$404M
| $333K | ﹤0.01% |
15,730
-1,150
| -7% | -$26.6K |
|
|
DM
2767
DELISTED
Desktop Metal, Inc.
DM
| $333K | ﹤0.01% |
22,774
-2,261
| -9% | -$37.6K |
|
2768
Applied Digital
APLD
$7.54B
| $332K | ﹤0.01% |
53,280
-29,900
| -36% | -$209K |
|
2769
Brady Corp
BRC
$4.54B
| $332K | ﹤0.01% |
6,052
-2,507
| -29% | -$129K |
|
|
CFB
2770
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $331K | ﹤0.01% |
32,835
-1,070
| -3% | -$11.7K |
|
2771
eHealth
EHTH
$43.2M
| $329K | ﹤0.01% |
44,490
| – | – |
|
|
ME
2772
DELISTED
23andMe Holding Co
ME
| $329K | ﹤0.01% |
16,815
+690
| +4% | +$19.3K |
|
2773
SAP
SAP
$200B
| $329K | ﹤0.01% |
2,541
+301
| +13% | +$41K |
|
2774
PMV Pharmaceuticals
PMVP
$62.9M
| $328K | ﹤0.01% |
53,470
+4,380
| +9% | +$30.1K |
|
2775
Cerus
CERS
$615M
| $327K | ﹤0.01% |
202,074
-70
| -0% | -$146 |
|
Similar funds
AllianceBernstein's Q3 2023 Portfolio in Review
As of Q3 2023, AllianceBernstein held 3,241 positions worth $235B, down 4.1% from $245B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.2%. AllianceBernstein opened 78 new positions and exited 57, leaving the 3,241-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2023 buy was CRH: 5,431,009 shares worth $297M.
- AllianceBernstein added most to Netflix in Q3 2023, an estimated $595M increase.
- AllianceBernstein's biggest Q3 2023 reduction was Apple, cutting an estimated $384M.
- AllianceBernstein fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $77.5M.
- AllianceBernstein's ten largest holdings make up 24% of its $235B portfolio in Q3 2023.
- AllianceBernstein opened 78 new positions and closed 57 in Q3 2023.
- AllianceBernstein's portfolio value fell 4.1% quarter-over-quarter to $235B.
Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.